The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Open accessAbstract
We tested the hypotheses that the glucagon response to hypoglycemia is reduced in patients who are approaching the insulin-deficient end of the spectrum of type 2 diabetes and that recent antecedent hypoglycemia shifts the glycemic thresholds for autonomic (including adrenomedullary epinephrine) and symptomatic responses to hypoglycemia to lower plasma glucose concentrations in type 2 diabetes. Hyperinsulinemic stepped hypoglycemic clamps (85, 75, 65, 55, and 45 mg/dl steps) were performed on two consecutive days, with an additional 2 h of hypoglycemia (50 mg/dl) in the afternoon of the first day, in 13 patients with type 2 diabetes—7 treated with oral hypoglycemic agents (OHA RX; mean [±SD] HbA1c 8.6 ± 1.1%) and 6 requiring therapy with insulin for an average of 5 years and with reduced C-peptide levels (insulin RX, HbA1c 7.5 ± 0.7%)—and 15 nondiabetic control subjects. The glucagon response to hypoglycemia was virtually absent (P = 0.0252) in the insulin-deficient type 2 diabetic patients (insulin RX mean [±SE] final values of 52 ± 16 vs. 93 ± 15 pg/ml in control subjects and 98 ± 16 pg/ml in type 2 diabetic patients, OHA RX on day 1). Glucagon (P = 0.0015), epinephrine (P = 0.0002), and norepinephrine (P = 0.0138) responses and neurogenic (P = 0.0149) and neuroglycopenic (P = 0.0015) symptom responses to hypoglycemia were reduced on day 2 after hypoglycemia on day 1 in type 2 diabetic patients; these responses were not eliminated, but their glycemic thresholds were shifted to lower plasma glucose concentrations. In addition, the glycemic thresholds for these responses were at higher-than-normal plasma glucose concentrations (P = 0.0082, 0.0028, 0.0023, and 0.0182, respectively) at baseline (day 1) in OHA RX type 2 diabetic patients, with relatively poorly controlled diabetes. Because the glucagon response to falling plasma glucose levels is virtually absent and the glycemic thresholds for autonomic and symptomatic responses to hypoglycemia are shifted to lower glucose concentrations by recent antecedent hypoglycemia, patients with advanced type 2 diabetes, like those with type 1 diabetes, are at risk for hypoglycemia-associated autonomic failure and the resultant vicious cycle of recurrent iatrogenic hypoglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, as patients approach the insulin-deficient end of the spectrum of T2DM (118), typically over many years, their insulin and glucagon responses to falling glucose levels are lost (90), as in T1DM.”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [90]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With the prolonged duration of type 2 diabetes as is often seen in the elderly patient, the glucagon response to hypoglycemia is virtually absent (55).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Furthermore, their glycemic thresholds for sympathoadrenal responses are shifted to lower plasma glucose concentrations by recent antecedent hypoglycemia (90), as in T1DM.”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [90]
In the citing paper
“The relevance of basing a biochemical definition for hypoglycaemia on the glycaemic threshold for secretion of glucagon can also be disputed, as this becomes deficient at an early stage of type 1 diabetes [12] and in type 2 diabetes when pancreatic beta cell failure is present [13].”
From Defining hypoglycaemia: what level has clinical relevance? (2009) · cites this paper as [13]
In the citing paper
“diabetes as is often seen in the elderly patient, the glucagon response to hypoglycemia is virtually absent (55).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [55]
In the citing paper
“The glucagon response to hypoglycemia was intact in the tablettreated patients and in the nondiabetic control subjects but was almost absent in the insulin-deficient patients (Fig. 4), demonstrating the presence of acquired counterregulatory abnormalities in association with insulin deficiency.”
From Hypoglycemia in Type 2 Diabetes (2005) · cites this paper as [51]
In the citing paper
“Thus, antecedent hypoglycemia can modify the glycemic thresholds for responses to hypoglycemia in type 2 diabetes and may promote HAAF (53).”
From Hypoglycemia in Type 2 Diabetes (2005) · cites this paper as [51]
In the citing paper
“The natural history of α-cell “blindness” is less clear in T2D but is thought to mirror the progression of endogenous insulin deficiency, which is much slower in T2D than T1D ( Segel et al., 2002 ; Zammitt and Frier, 2005 ).”
From Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes (2024) · cites this paper as Segel et al., 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923
Turner, R., Stratton, I., Horton, V., Manley, S., Zimmet, P., Mackay, I. R., Shattock, M., Bottazzo, G. F., & Holman, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03062-6 · Cited by 779
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., & Forsham, P. H. (1973) · Science · doi:10.1126/science.182.4108.171 · Cited by 688
Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics
Kuzuya, H., BLIX, P. M., Horwitz, D. L., Steiner, D. F., & Rubenstein, A. H. (1977) · Diabetes · doi:10.2337/diab.26.1.22 · Cited by 603
Heller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Self-citationDagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471
Self-citationBolli, G., Feo, P. D., Compagnucci, P., Cartechini, M. G., Angeletti, G., Santeusanio, F., Brunetti, P., & Gerich, J. E. (1983) · Diabetes · doi:10.2337/diab.32.2.134 · Cited by 433
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.
Cranston, I., Lomas, J., Amiel, S. A., Maran, A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91336-6 · Cited by 430
Cited by
Sorted by citations
Items 201–300 of 336
Boada, C. A. C., & Martínez-Moreno, J. M. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6707 · Cited by 8
Hypoglycaemia in Type 2 Diabetes and in Elderly People
Zammitt, N. N., & Frier, B. M. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch12 · Cited by 8
Hoffman, E. G., D’Souza, N. C., Aiken, J., ATHERLEY, S. C., Liggins, R., & Riddell, M. C. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15002 · Cited by 8
Efficacy and Safety of Naproxen for Acute Pain
Weisman, S. R. (2020) · The Journal of Family Practice · doi:10.12788/jfp.0064 · Cited by 8
Olamoyegun, M. A., Ala, O. A., Enikuomehin, A. C., & Akinlade, A. T. (2020) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2020.102005 · Cited by 7
Hypoglycemia: Essential Clinical Guidelines
Paluchamy, T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.86994 · Cited by 10
Farhy, L. S., & McCall, A. L. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300104 · Cited by 7
Managing the Burden of Dementia-Related Delusions and Hallucinations
Small (2020) · The Journal of Family Practice · doi:10.12788/jfp.0065 · Cited by 6
Zaghlol, L. Y., Beirat, A. F., Amarin, J. Z., Najar, A. M. H. A., Hasan, Y. Y., Qtaishat, A., Tierney, M. E., Zaghlol, R. Y., & Zayed, A. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.613826 · Cited by 7
Fabricius, T. W., Verhulst, C. E. M., Kristensen, P. L., Holst, J. J., Tack, C. J., McCrimmon, R. J., Heller, S. R., Evans, M. L., de Galan, B. E., & Pedersen‐Bjergaard, U. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02239-8 · Cited by 7
Hypoglycaemia in patients with type 2 diabetes: minimising the risk
Fisher, M. (2010) · The British Journal of Diabetes · doi:10.1177/1474651409356092 · Cited by 6
Perl, S., Cook, W., Wei, C., Öhman, P., & Hirshberg, B. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.10.006 · Cited by 6
Ishikawa-Tanaka, T., Hosojima, M., Kabasawa, H., Kaseda, R., Yasukawa, R., Yata, Y., Kuwahara, S., Kono, E., Takata, T., Iino, N., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00928-5 · Cited by 6
Betten, D. P., Castle, D. J., Hughes, M. J., & Henney, J. N. (2018) · International Journal of Emergency Medicine · doi:10.1186/s12245-018-0186-7 · Cited by 6
Breum, L., Almdal, T., Eiken, P., Lund, P., & Christiansen, E. (2008) · The Review of Diabetic Studies · doi:10.1900/rds.2008.5.154 · Cited by 6
Breton, M. D., Clarke, W. L., Farhy, L. S., & Kovatchev, B. P. (2007) · Journal of Diabetes Science and Technology · doi:10.1177/193229680700100304 · Cited by 6
He, Y., Kunutsor, S. K., Kingsnorth, A. P., Gillies, C., Choudhary, P., Khunti, K., & Zaccardi, F. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15677 · Cited by 5
Optimal Glycemic Control in the Elderly: Where is the Evidence and Who Should Be Targeted?
Tessier, D. (2011) · Aging Health · doi:10.2217/ahe.10.86 · Cited by 5
Amiel, S. A., & Cryer, P. E. (2009) · Diabetes · doi:10.2337/db08-1647 · Cited by 5
Self-citationAcute Diabetic Emergencies, Hypoglycemia, and Glycemic Control
Chansky, M. E., & Haddad, G. (2008) · Elsevier eBooks · doi:10.1016/b978-032304841-5.50061-3 · Cited by 5
Hypoglycemia and Hypoglycemic Syndromes
Davis, S. N., Lamos, E. M., & Younk, L. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00047-0 · Cited by 5
Wing, J., & Jivan, D. (2015) · South African Medical Journal · doi:10.7196/samj.2016.v106i1.10284 · Cited by 5
D’Souza, N. C., Aiken, J., Hoffman, E. G., ATHERLEY, S. C., Champsi, S., ALEALI, N., Shakeri, D., El-Zahed, M., Akbarian, N., Nejad-Mansouri, M., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1302015 · Cited by 5
Wong, C., de Bray, A., Hassan, N. U., Almohandes, A., Thant, K. Z., Gill, S., Gill, D., Forsdick, H., Sinclair, A. J., Karamat, M. A., et al. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241269133 · Cited by 5
Gao, R., Acreman, S., Dou, H., Ma, J., MIRANDA, C. A., Zhao, R., Dickerson, M. T., Tarasov, A. I., Zou, Q., Gironella-Torrent, M., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-025-01422-7 · Cited by 4
Schwartz, X., Porter, B. A., Gilbert, M. P., Sullivan, A., Long, B., & Lentz, S. A. (2023) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2023.04.018 · Cited by 4
Alsharif, A. A., Wong, I. C. K., Ma, T., Lau, W. C. Y., Alhamed, M., Alwafi, H. H., & Wei, L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1177636 · Cited by 4
Glucose Counterregulation in Advanced Type 2 Diabetes: Effect of β-Adrenergic Blockade
Bokhari, S. M. N. A., Plummer, E., Emmerson, P., Gupta, A., & Meyer, C. (2014) · Diabetes Care · doi:10.2337/dc14-0782 · Cited by 4
Hypoglykämien: Ein ernstzunehmendes Problem in der Diabetesbehandlung
Krichbaum, M., & Kulzer, B. (2011) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 4
Biomarkers associated with severe hypoglycaemia and death in ACCORD
Chow, L. S., CHEN, H.-Y. P., Miller, M. E., Marcovina, S. M., & Seaquist, E. R. (2015) · Diabetic Medicine · doi:10.1111/dme.12883 · Cited by 4
Cryer, P. E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00034-1 · Cited by 5
Self-citationKern, W. (2013) · Der Diabetologe · doi:10.1007/s11428-012-0907-0 · Cited by 3
Glucagon-like peptide-1 and impaired counterregulatory responses to hypoglycemia in type 1 diabetes
Rocha, G. R., & de Melo, F. F. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v16.i2.99928 · Cited by 3
Goh, H. K., Chew, D. E. K., Miranda, I. G., Tan, L. A., & Lim, G. H. (2009) · Emergency Medicine Journal · doi:10.1136/emj.2008.062232 · Cited by 3
Cruz, A. M., Partridge, K. M., Malekizadeh, Y., Walker, J. M. V., Potter, P. G. W., Pye, K. R., Shaw, S. J., Ellacott, K. L. J., & Beall, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.697445 · Cited by 3
Cryer, P. E. (2021) · Contemporary Endocrinology · doi:10.1007/978-3-030-67455-7_3 · Cited by 3
Self-citationHaas, A. V., Koefoed, A. W., Easly-Merski, R., Celli, J., Heydarpour, M., Bonyhay, I., Freeman, R. L., & Adler, G. K. (2023) · Clinical Autonomic Research · doi:10.1007/s10286-023-00983-5 · Cited by 6
Savage, K. T., Chen, J. W., Schlenker, K., Pugliano‐Mauro, M. A., & Carroll, B. T. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2024.02.060 · Cited by 3
Jiménez-Montero, J. G., Solórzano, M. L. C., & Barakat, M. V. (2020) · Diabetes & its Complications · doi:10.33425/2639-9326.1068 · Cited by 3
Kodl, C. T., & Seaquist, E. R. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0065-3 · Cited by 3
Neural Network Modeling Approaches for Patient Specific Glycemic Forecasting
Pappada, S. M., & Cameron, B. D. (2011) · Studies in mechanobiology, tissue engineering and biomaterials · doi:10.1007/8415_2011_98 · Cited by 3
Hypoglycemia and the central nervous system
McCall, A. L. (2002) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200208000-00008 · Cited by 3
Iloh, G. U. P., & Collins, P. (2017) · BLDE University Journal of Health Sciences · doi:10.4103/bjhs.bjhs_5_17 · Cited by 3
Silent Myocardial Infarction and Hypoglycaemia
Goh, H. K., Chia, M. Y. C., Ooi, Y. W., & Chew, D. E. K. (2010) · The Endocrinologist · doi:10.1097/ten.0b013e3181c9f58d · Cited by 3
Weir (2020) · The Journal of Family Practice · doi:10.12788/jfp.0068 · Cited by 3
Recognition and Management of Hypoglycemia
Shubrook (2020) · The Journal of Family Practice · doi:10.12788/jfp.0069 · Cited by 3
Potter, P. G. W., Washer, S. J., Jeffries, A. R., Holley, J. E., Gutowski, N. J., Dempster, E. L., & Beall, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.671724 · Cited by 3
Hypoglycemia-Associated Autonomic Failure in Diabetes
Cryer, P. E., & Arbeláez, A. M. (2018) · Contemporary Endocrinology · doi:10.1007/978-3-319-77048-2_13 · Cited by 3
Self-citationThe Parodox of Glycemic Control and Cardiovascular Complications: Sorting Out the Data
Dokken, B. B. (2008) · Diabetes Spectrum · doi:10.2337/diaspect.21.3.150 · Cited by 3
Glucagon in health and diabetes
Chawla, R., & Jaggi, S. (2023) · Journal of Diabetology · doi:10.4103/jod.jod_102_23 · Cited by 2
Hypoglycaemia in Type 2 Diabetes – Clinical Consequences and Impact on Treatment
Mathieu, C., FILOZOF, C. M., & Barnett, A. H. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2010.06.00.29 · Cited by 2
Hypoglycemia in diabetic pregnancy
Cianni, G. D., Lencioni, C., Lacaria, E., & Russo, L. (2018) · CRC Press eBooks · doi:10.1201/9781315382104-52 · Cited by 2
S2e-Leitlinie Diabetes und Straßenverkehr
(DDG), D. D. G., Ebert, O., Bohn, B., Bertram, B., Buchberger, B., Finck, H., Hoß, J., Hubner, P. J. B., Krabbe, L. M., Kulzer, B., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/s-0043-124953 · Cited by 2
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_22-2 · Cited by 2
Chow, E., & Heller, S. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8684-8_34 · Cited by 2
Hypoglycemia in Type 2 Diabetes
Cryer, P. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-17 · Cited by 2
Self-citationMcDougal, D. H., Darpolor, M. M., DuVall, M. A., Sutton, E. F., Morrison, C. D., Gadde, K. M., Redman, L. M., & Carmichael, O. T. (2018) · Acta Diabetologica · doi:10.1007/s00592-018-1180-5 · Cited by 2
Preoperative Hypoglycemia Increases Infection Risk After Trigger Finger Injection and Release
Buchanan, P. J., Law, T. Y., Rosas, S., Hubbard, Z., Mast, B. A., & Chim, H. (2018) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000001667 · Cited by 2
Hypoglycemia in Type 2 Diabetes
Cryer, P. E. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-043-4_13 · Cited by 2
Self-citationCounterregulatory Deficiencies in Diabetes
McCrimmon, R. J. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch3 · Cited by 2
Hipoglucemia en la diabetes, fisiopatología, clínica y tratamiento
Cabezas-Cerrato, J. (2004) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(04)70155-1 · Cited by 2
Kim, Y. J., Choi, J. Y., & Kim, K. R. (2016) · International Journal of Bio-Science and Bio-Technology · doi:10.14257/ijbsbt.2016.8.2.38 · Cited by 1
Counterregulatory responses of healthy cats to insulin-induced hypoglycemia
Mott, J., Adin, C. A., Crews, C. D., Salute, M. E., Tardo, A. M., Porter, L. T., Berg, A. S., & Gilor, C. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00269.2024 · Cited by 1
Worku, Y. B., Tekle, M. T., Bekalu, A. F., & Simegn, M. B. (2025) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2025.1320610 · Cited by 1
TRPM7 kinase regulates α-cell proliferation and glucagon production in mice
Boulassel, S., Schreier, P. C. F., Beck, A., Choi, H., Melyshi, A. M., Reinach, P. S., Duraj, M., Vinogradov, M., Suleimen, B., Berger, J., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102317 · Cited by 1
Li, J., Yuan, J., Zhang, Y., Zeng, Q., & Ma, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1834479 · Cited by 1
Hypoglycemia in Diabetes Mellitus
Alsahli, M., & Gerich, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_19 · Cited by 1
Hipoglucemia en pacientes diab?ticos tipo 2
Gonzlez, J. P. M., Prez, E. P., Martín-Oterino, J.-Á., & Cengoitiabengoa, M. B. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73228-4 · Cited by 1
1. Epidemiology and Impact of Hypoglycemia on Patients with Diabetes
Frier, B. M., & Heller, S. R. (2012) · Translational endocrinology & metabolism · doi:10.1210/team.9781936704200.ch1 · Cited by 1
Hypoglycemia and Hypoglycemic Syndromes
Davis, S. N. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00047-2 · Cited by 1
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_22 · Cited by 3
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_22 · Cited by 1
Hypoglycemia—The Major Barrier to Good Glycemic Control
Davis, S. N., & Dunn, J. P. (2006) · US Endocrinology · doi:10.17925/use.2006.00.1.2f · Cited by 1
Cryer, P. E. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-697-9_3 · Cited by 1
Self-citationLee, W. K., Ko, M. S. M., Ang, L. C., Zhu, L., Bee, Y. M., Goh, S., & Teh, M. M. (2023) · Diabetic Medicine · doi:10.1111/dme.15215 · Cited by 1
Krishnamoorthy, S., Pandurangan, V., Varadan, S., Gopalan, S., & Singh, S. (2024) · Scripta Medica · doi:10.5937/scriptamed55-50079 · Cited by 1
Treatment Strategy to Prevent Hypoglycemia
Han, S. J. (2016) · Journal of Korean Diabetes · doi:10.4093/jkd.2016.17.1.30 · Cited by 1
Cryer, P. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00034-4 · Cited by 1
Self-citationZbyt intensywne leczenie chorych na cukrzycę typu 2 w wieku podeszłym
Mikołajczyk-Solińska, M., Kosmalski, M., & Drzewoski, J. (2018) · Clinical Diabetology · doi:10.5603/dk.2018.0004 · Cited by 1
Hypoglycemia and the risk of stroke in patients with type 2 diabetes mellitus in older age groups
Ostroumova, O. D., Starodubova, A. V., Alexey, I. K., De, V. A., Оstroumova, Т. М., & Kiknadze, T. D. (2020) · Medical news of the North Caucasus · doi:10.14300/mnnc.2020.15144 · Cited by 1
Addressing Nutritional Gaps: Simple Steps for the Primary Care Provider
Quan, Q. (2020) · The Journal of Family Practice · doi:10.12788/jfp.0059 · Cited by 1
An Individualized, Case-Based Approach to the Management of Irritable Bowel Syndrome
Lacy (2020) · The Journal of Family Practice · doi:10.12788/jfp.0060 · Cited by 1
Clinical Audit on Hypoglycemic Symptoms in Type 2 Diabetic Patients
Hunnain, F. (2022) · International Journal of Current Science Research and Review · doi:10.47191/ijcsrr/v5-i6-35
Microdialysis as a Monitoring System for Human Diabetes
Ciechanowska, A., Wojcicki, J. M., Maruniak‐Chudek, I., Ładyżyński, P., & Krzymień, J. (2011) · Wiley eBooks · doi:10.1002/9781118011294.ch12 · Cited by 1
Hypoglycemia unawareness syndrome. Risk factors and treatment
Ampudia‐Blasco, F. J. (2009) · Cited by 1
Potter, P. G. W., Walker, J. M. V., Robb, J. L., Chilton, J. K., Williamson, R., Randall, A. D., Ellacott, K. L. J., & Beall, C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/271981 · Cited by 1
Cryer, P. E., & Frier, B. M. (2004) · International Textbook of Diabetes Mellitus · doi:10.1002/0470862092.d0707 · Cited by 1
Self-citationHypoglycemia in diabetic pregnancy
Lapolla, A., Dalfrà, M. G., Lencioni, C., & Cianni, G. D. (2008) · Series in maternal-fetal medicine · doi:10.3109/9781439802007.032 · Cited by 1
GDF15 is a Critical Renostat in the Defense Against HypoglycemiaPreprint
Li, Z., Zhang, X., Zhu, W., Xu, Q. J., Yu, C. D., Zhao, Q., Siebel, S., Zhang, C., Lima, B. G. C., Li, X., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.22.546095 · Cited by 2
Glucosensing, Hypoglycemia, and the Brain
Reno, C. M. (2013) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7xw4gs6
Hypoglycemia caused by Insulin Secretagogues
Tentolouris, N., & Katsilambros, N. L. (2011) · Wiley eBooks · doi:10.1002/9781119971825.ch5
Ponce, M., & Stalin, L. (2014) · Americanae (AECID Library)
Gestione del paziente diabetico (escluso il diabete gestazionale e il diabete nei bambini)
Ouattara, T. N. T., & Raucoules-Aimé, M. (2015) · EMC - Anestesia-Rianimazione · doi:10.1016/s1283-0771(15)73955-1
Hypoglycemic Associated Autonomic Dysfunction
Sandoval, D. A., & Davis, S. N. (2004) · Elsevier eBooks · doi:10.1016/b978-012589762-4/50108-0
Mechanisms of hypoglycaemia related sudden cardiac death in type 2 diabetes mellitus
Chow, E. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
CLINICAL ASPECTS ON GLUCOSE-LOWERING THERAPIES IN TYPE 2 DIABETES
Nybäck‐Nakell, Å. (2012) · Figshare
The Hypoglycemia Evaluated Mistakenly as Cerebrovascular Disease
Coşkun, D., Mahli, A., Camgoz, N., Koksal, F., Tarhan, B., & Karabıyık, L. (2011) · Journal of Neurology Research · doi:10.4021/jnr.v1i1.17
Comment se parlent les cellules α et β du pancréas … ?
Dolz, M. (2008) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(08)71669-9
Retropharyngeal abscess secondary to a foreign body
Rumbold, H. (2009) · Emergency Medicine Journal · doi:10.1136/emj.2008.064956
Breton, M. D., Farhy, L. S., Penberthy, J. K., & Kovatchev, B. P. (2006) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2006.260113
Metadata
- Authors
- Segel, S. A., Paramore, D. S., & Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2002-03-01
- Volume
- 51
- Issue
- 3
- Pages
- 724-733
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2169041612
- Semantic Scholar
- e27fce60297b1def45cb9f8bc74a2f09363a73ad
- Cited by
- 337
- References
- 45
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 11 · 2022: 6 · 2021: 9 · 2020: 23 · 2019: 8 · 2018: 19 · 2017: 7 · 2016: 15 · 2015: 19 · 2014: 11 · 2013: 20 · 2012: 13
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5p60dk020579-35)
- U.S. Public Health Service (P60-DK-20579)
- National Institute of Diabetes and Digestive and Kidney Diseases (P60-DK20579, R01-DK-27085, T32 DK07120, R01DK027085, T32DK007120)
- National Center for Research Resources (M01-RR00036, M01RR000036)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- hypoglycemia-associated autonomic failure, type 2 diabetes, insulin deficiency, epinephrine response, norepinephrine response, neuroglycopenic symptoms, glycemic thresholds, hypoglycemic clamp, oral antidiabetic drugs, insulin therapy
- MeSH terms
- Adult, Autonomic Nervous System, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Epinephrine, Female, Glucagon, Glycated Hemoglobin, Humans, Hypoglycemia, Insulin, Kinetics, Male, Middle Aged, Norepinephrine, Glucose Clamp Technique
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
